Featured Articles

51. GE Healthcare Launches Super-Resolution Microscope 9/23/2019

    GE Healthcare launches a new microscope to support researchers and their ever-increasing need to see extreme details in cells, without having to choose whether speed, depth or clarity is more important. The DeltaVision OMX Flex super-resolution microscope is a highly stable, multichannel imaging platform optimized for structured illumination microscopy (SIM), and now includes EDGE confocal technology.

52. Sensitive And Reproducible SPR-Based Concentration And Ligand-Binding Analyses 3/27/2019

    Surface plasmon resonance (SPR) assays are used across the life cycle of a biopharmaceutical, from target identification, through CQA determination, development, and on-going quality control. This article focuses on concentration assays associated with late-stage development and biotherapeutic drug chemical manufacturing and control.

53. Western Blot Detection: Is Film Or A Digital CCD Imager Better? 4/26/2018

    Learn the benefits and drawbacks of using film or a CCD imager to detect the bound antibody in Western blotting, also known as immunoblotting.

54. Stripping And Reprobing Western Blot Membrane: Problems And Solutions 4/26/2018

    Ways of maximizing your Western blot membrane use by stripping and reprobing with another primary antibody.

55. Stripping Membranes For Reprobing 4/26/2018

    Detect more than one protein by chemiluminescence on the same Western blot membrane by stripping and reprobing the membrane with a different primary antibody.

56. How Label-Free Assays Are Employed In The Immunogenicity Workflow 2/21/2018

    Examples of how label-free biophysical binding assays are successfully employed in all steps in the immunogenicity workflow to ensure confident detection, confirmation, and comprehensive characterization of immune responses.

57. Concentration And Ligand-Binding Analyses In Late-Stage Development And Quality Control Of Biotherapeutics 2/21/2018

    Review the use of Biacore for active concentration measurements, target binding, and Fc receptor (FcR) analysis along with the use of these assays for assessment of drug potency and stability.

58. GE Healthcare Launches FF High Performance Nitrocellulose Membranes Optimized For Diagnostic Assay Reproducibility 8/1/2012

    GE Healthcare Life Sciences’ new Whatman FF High Performance (HP) membrane provides the industry with a new diagnostic membrane to enable fast, razor-sharp line separation and highly reproducible results for the detection of target molecules in liquids such as water, urine, blood and saliva.

59. Why, Why, Why… ELISA? A Look At The Benchmark HCP Assay

    Biologics developers and manufacturers demand an accurate and reliable assay for host cell protein (HCP) quantitation. Let’s take a close look at why analytical scientists turn to the ELISA, and how it fits into process development.

60. Research And Industry Join Forces As Modalities Merge

    How is current research driving the convergence of therapeutic modalities, and what implications does this have for patients and healthcare? Read on to find answers to these questions and more.